Arcus Biosciences (RCUS) Accumulated Depreciation & Amortization (2017 - 2024)
Historic Accumulated Depreciation & Amortization for Arcus Biosciences (RCUS) over the last 8 years, with Q4 2024 value amounting to $10.0 million.
- Arcus Biosciences' Accumulated Depreciation & Amortization rose 2500.0% to $10.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.0 million, marking a year-over-year increase of 2500.0%. This contributed to the annual value of $10.0 million for FY2024, which is 2500.0% up from last year.
- Per Arcus Biosciences' latest filing, its Accumulated Depreciation & Amortization stood at $10.0 million for Q4 2024, which was up 2500.0% from $8.0 million recorded in Q4 2023.
- Arcus Biosciences' 5-year Accumulated Depreciation & Amortization high stood at $14.3 million for Q4 2020, and its period low was $4.0 million during Q4 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $8.5 million, with a median of $8.0 million in 2023.
- As far as peak fluctuations go, Arcus Biosciences' Accumulated Depreciation & Amortization tumbled by 7200.45% in 2021, and later skyrocketed by 5000.0% in 2022.
- Arcus Biosciences' Accumulated Depreciation & Amortization (Quarter) stood at $14.3 million in 2020, then crashed by 72.0% to $4.0 million in 2021, then skyrocketed by 50.0% to $6.0 million in 2022, then surged by 33.33% to $8.0 million in 2023, then increased by 25.0% to $10.0 million in 2024.
- Its Accumulated Depreciation & Amortization was $10.0 million in Q4 2024, compared to $8.0 million in Q4 2023 and $6.0 million in Q4 2022.